Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05003141
Title PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Qilu Puget Sound Biotherapeutics (dba Sound Biologics)
Indications

chronic lymphocytic leukemia/small lymphocytic lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

MALT lymphoma

chronic lymphocytic leukemia

follicular lymphoma

mantle cell lymphoma

Waldenstroem's macroglobulinemia

Therapies

PSB202

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.